LEGUBETI

LOE Approaching

acetylcysteine lysine

R-Pharm US
NDAORALFOR SOLUTION
Approved
Feb 2024
Lifecycle
LOE Approaching
Competitive Pressure
35/100

Loss of Exclusivity

LOE Date
Feb 13, 2027
11 months away
Exclusivity Expiry
Feb 13, 2027
Company
R-Pharm US
R-Pharm US
NJ - Princeton
External Resources
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers